If you are at risk of developing diabetes, high blood pressure, heart disease, all these things that obesity can contribute to, then I would argue that its not a good thing, but its not about shaming. Public health approach Sceppa stresses that while GLP-1 medications can drive weight loss, they also come with trade-offs
I started medication and my care plan immediately after signing up
Instead, ask your pharmacy if alternative flavoring options are available
People with T1D face significantly elevated risks of cardiovascular disease and kidney disease over time, and GLP-1 drugs have shown powerful protective effects in those areas in people with type 2 diabetes and obesity
Brain glucagon-like peptide 1 signaling controls the onset of high-fat diet-induced insulin resistance and reduces energy expenditure
Multiple Sclerosis Considering the potential of GLP-1RAs for the treatment of NDD, multiple sclerosis, a chronic progressive autoimmune disease caused by autoantibodies that stimulate inflammation and destruction of the myelin sheath of neuronal axons, disrupting axonal conduction and function should also be mentioned
